Delivery Order SPE2DB20D6035-SPE2DB25FLYEP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dasatinib 80 mg tablets (30-count packaging) under a firm fixed-price contract valued at $82,393.53. The order is set to be completed by July 29, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $9,193.03 to AmerisourceBergen Drug Corp for Dasatinib 50 mg tablets (60-count supply) on August 11, 2025, with a completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $30,587.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Dasatinib 50 mg tablets, with an ultimate completion date of July 29, 2025. This non-set-aside contract was competitively awarded on July 28, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,632.41, is for the delivery of the medication Dasatinib 100 mg tablets. The contract is a firm fixed-price, non-set-aside delivery order with a performance period through May 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of 100 mg Dasatinib tablets, with a ceiling value of $27,673.65 and a period of performance through June 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a for-profit corporate entity that serves as a critical supplier of medical and pharmaceutical...
- This federal contract award, valued at $5,456.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4568096600 - Dasatinib 20 mg Tablet 60s, a prescription medication, with a completion date of May 2, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,901.87 firm-fixed-price delivery order is for the supply of DASATINIB 50 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 23, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $18,543.22 to AmerisourceBergen Drug Corp for the supply of Sprycel 70 mg tablets (60-count units). This competitive award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,363.69, is for the delivery of DASATINIB 80 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of July 1, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30-count bottles of the prescription medication Dasatinib 80 mg tablets, with a total ceiling value of $8,260.58 and a final completion date of July 10, 2025. The contract is not set aside and was awarded on July 9, 2025. Amerisourcebergen Drug Corp is a for-profit...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB25FLYEPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,260.56 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units) with a firm fixed price structure. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively made with no set-aside designation, and delivery is scheduled for completion by August 5, 2025, with the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive portfolio of pharmaceutical products and medical supplies. The SPE2DX vehicle supports military healthcare programs globally by providing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Dasatinib—a targeted cancer therapy commonly used to treat chronic myeloid leukemia and acute lymphoblastic leukemia—exemplifies the company's role in supplying specialized pharmaceutical products essential to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 8/4/25 |